Medicare Enrolled

Dr. Neil Gershman, M.D.

Allergy & Immunology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7800 SW 87TH AVE, Miami, FL 33173
3055950109
In practice since 2005 (20 years)
NPI: 1851389985 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gershman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gershman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gershman

Dr. Neil Gershman is an allergy & immunology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gershman performed 23,084 Medicare services across 870 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gershman received a total of $19,033 from 37 pharmaceutical and/or device companies across 677 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gershman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in FL$ $19,033 industry payments

Medicare Practice Summary

Medicare Utilization ↗
23,084
Medicare services
Top 11% in FL for allergy & immunology
870
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,154 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, tezepelumab-ekko, 1 mg8,197$14$48
Omalizumab injection (Xolair) for asthma/allergy5,012$30$111
Allergy skin test4,950$3$10
Allergy immunotherapy preparation1,550$11$35
Test for allergy using allergenic extract injected into skin1,268$6$12
Allergy injection therapy, multiple injections966$9$35
Office visit, established patient (20-29 min)356$67$149
Drug injection, under skin or into muscle265$11$54
Administration and interpretation of patient-focused health risk assessment148$2$16
Professional service for single injection of allergen105$7$30
New patient office visit (45-59 min)92$118$324
Test to measure expiratory airflow and volume changes before and after medication administration58$29$250
Test to measure expiratory airflow and volume56$21$149
Office visit, established patient (30-39 min)47$93$175
Test to measure the level of nitric oxide gas14$14$30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,033
Total received (2018-2024)
Avg $2,719/year across 7 years
Top 18% in FL for allergy & immunology
37
Companies
677
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,459 (91.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,558 (8.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,935
2023
$3,345
2022
$2,363
2021
$2,160
2020
$1,542
2019
$2,723
2018
$3,965

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,234
GlaxoSmithKline, LLC.
$3,125
ALK-Abello, Inc
$2,120
GENZYME CORPORATION
$2,090
Regeneron Healthcare Solutions, Inc.
$915
Takeda Pharmaceuticals U.S.A., Inc.
$670
CSL Behring
$659
Boehringer Ingelheim Pharmaceuticals, Inc.
$647
PFIZER INC.
$532
Pharming Healthcare, Inc.
$419
Optinose US, Inc.
$392
Octapharma USA, Inc.
$356
OptiNose US, Inc.
$337
LEO Pharma Inc.
$324
BioCryst US Sales Co., LLC
$297
Amgen Inc.
$297
Novartis Pharmaceuticals Corporation
$277
Shire North American Group Inc
$276
Blueprint Medicines Corporation
$272
Genentech USA, Inc.
$229
kaleo, Inc.
$214
ABBVIE INC.
$164
Incyte Corporation
$139
X4 Pharmaceuticals, Inc.
$135
Sunovion Pharmaceuticals Inc.
$129
Teva Pharmaceuticals USA, Inc.
$125
Kaleo, Inc.
$121
Grifols USA, LLC
$116
SANOFI-AVENTIS U.S. LLC
$99
Grifols Shared Services North America, Inc.
$94
Mylan Specialty L.P.
$78
AIMMUNE THERAPEUTICS, INC.
$52
Bio Products Laboratory USA, Inc.
$27
Aimmune Therapeutics, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
ADMA BioManufacturing LLC
$16
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 44.5% of total payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ANORO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · ArmonAir Digihaler · Auvi-Q · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FARXIGA · FASENRA · GLASSIA · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · Kcentra · LATUDA · LONHALA MAGNAIR · NUCALA · OPZELURA · ORLADEYO · Odactra · PALFORZIA · PANZYGA · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · RINVOQ · RUCONEST · Ragwitek · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Utibron · XOLAIR · XOLREMDI · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $82 per 100 Medicare services performed
Looking for a allergy & immunology in Miami?
Compare allergy & immunologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologys nearby

Geographic Context

Allergy & Immunologys within 10 mi
46
Per 100K population
1.7
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gershman is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gershman experienced with injection, tezepelumab-ekko, 1 mg?
Based on Medicare claims data, Dr. Gershman performed 8,197 injection, tezepelumab-ekko, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gershman receive payments from pharmaceutical companies?
Yes. Dr. Gershman received a total of $19,033 from 37 companies across 677 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gershman's costs compare to other allergy & immunologys in Miami?
Dr. Gershman's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gershman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →